Pregnancy-associated plasma protein A (PAPP-A) and soluble receptor for advanced glycation end products (sRAGE) – intra- and inter-individual variability in chronic hemodialysis patients

References

• Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant 2003;18:1272–80.
   PubMed Web of Science ®Google Scholar
• Kalousova M, Sulkova S, Fialova L, Soukupova J, Malbohan IM, Spacek P, Braun M, Mikulikova L, Fortova M, Horejsi M, Tesar V, Zima T. Glycoxidation and inflammation in chronic hemodialysis patients. Nephrol Dial Transplant 2003;18:2577–81.
   PubMed Web of Science ®Google Scholar
• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685–95.
   PubMed Web of Science ®Google Scholar
• Nozaki T, Sugiyama S, Koga H, Sugamura K, Ohba K, Matsuzawa Y, Sumida H, Matsui K, Jinnouchi H, Ogawa H. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease. J Am Coll Cardiol 2009;54:601–8.
   PubMed Web of Science ®Google Scholar
• Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Simoons ML, Zeiher AM and CAPTURE Study Investigators. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 2005;45:229–37.
   PubMed Web of Science ®Google Scholar
• Hudson BI, Harja E, Moser B, Schmidt AM. Soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease. The next C-reactive protein? Arterioscler Thromb Vasc Biol 2005;25:879–82.
   PubMed Web of Science ®Google Scholar
• Pullerits R, Bokarewa M, Dahlberg R, Tarkowski A. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther 2005;7: 817–24.
   PubMed Web of Science ®Google Scholar
• Bunn RC, FowlkesJL. Insulin-like growth factor binding protein proteolysis. Trends Endocrinol Metab 2003;14: 176–81.
   PubMed Web of Science ®Google Scholar
• Conti E, Andreotti F, Zuppi C. Pregnancy-associated plasma protein-A as predictor of outcome in patients with suspected acute coronary syndromes. Circulation 2004;109:211–2.
   Google Scholar
• Conti E, Carrozza C, Capoluongo E, Volpe M, Crea F, Zuppi C, Andreotti F. Insulin-like growth factor-1 as vascular protective factor. Circulation 2004;110:2260–5.
   PubMed Web of Science ®Google Scholar
• Andreotti F, Becker RC. Atherothrombotic disorders: new insights from hematology. Circulation 2005;111:1855–63.
   Google Scholar
• Capoluongo E, Ameglio F, Lulli P, Minucci A, Santonocito C, Concolino P, Di Stasio E, Boccaci S, Vendettuoli V, Giuratrabocchetta G, De Cunto A, Tana M, Romagnoli C, Zuppi C, Vento G. Epithelial lining fluid free IGF-I-to-PAPP-A ratio is associated with bronchopulmonary dysplasia in preterm infants. Am J Physiol Endocrinol Metab 2007;292:308–13.
   PubMed Web of Science ®Google Scholar
• Crea F, Andreotti F. Pregnancy associated plasma protein-A and coronary atherosclerosis: marker, friend or foe? Eur Heart J 2005;26:2075–6.
   Google Scholar
• Kalousova M, Horejsi M, Fialova L, Soukupova J, Sulkova S, Malbohan I, Tesar V, Zima T. Increased levels of pregnancy-associated plasma protein A (PAPP-A) are associated with mortality of haemodialysis patients: preliminary results. Blood Purif 2004;22:298–300.
   PubMed Web of Science ®Google Scholar
• Etter C, Straub Y, Hersberger M, Räz HR, Kistler T, Kiss D, Wüthrich RP, Gloor HJ, Aerne D, Wahl P, Klaghofer R, Ambühl PM. Pregnancy-associated plasma protein-A is an independent short-time predictor of mortality in patients on maintenance haemodialysis. Eur Heart J 2010;31:354–9.
   PubMed Web of Science ®Google Scholar
• Kalousová M, Benáková H, Kubena AA, Dusilová-Sulková S, Tesar V, Zima T. Pregnancy-associated plasma protein A (PAPP-A) as an independent mortality predictor in long-term hemodialysis patients. Kidney Blood Press Res 2012;35:192–201.
   PubMed Web of Science ®Google Scholar
• Schmidt AM, Yanc SD, Yana SF, Stern DM. The biology of the receptor for advanced glycation end products and its ligand. Biochim Biophys Acta 2000;1498:99–111.
   PubMed Web of Science ®Google Scholar
• Basta G. Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications. Atherosclerosis 2008;196:9–21.
   PubMed Web of Science ®Google Scholar
• Kalousová M, Hoďková M, Kazderová M, Fialová J, Tesar V, Dusilová-Sulková S, Zima T. Soluble receptor for advanced glycation end products in patients with decreased renal function. Am J Kidney Dis 2006;47:406–11.
   PubMed Web of Science ®Google Scholar
• Kalousová M, Jáchymová M, Mestek O, Hodková M, Kazderová M, Tesar V, Zima T. Receptor for advanced glycation end products – soluble form and gene polymorphisms in chronic haemodialysis patients. Nephrol Dial Transplant 2007;22:2020–6.
   PubMed Web of Science ®Google Scholar
• Geroldi D, Falcone C, Emanuele E, D'Angelo A, Calcagnino M, Buzzi M, Scioli GA, Fogari R. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J Hypertens 2005;23: 1725–9.
   PubMed Web of Science ®Google Scholar
• Park L, Roman KG, Kee KJ, Lu Y, Ferran LJ Jr, Chow WS, Stern D, Schmidt AM. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation end products. Nat Med 1998;4:1025–31.
   PubMed Web of Science ®Google Scholar
• Armitage P, Berry G. Statistical methods in medical research, 3rd edn. London: Blackwell Science, 1994.
   Google Scholar
• Tsirpanlis G, Bagos P, Ioannou D, Bleta A, Marinou I, Lagouranis A, Chatzipanagiotou S, Nicolaou C. The variability and accurate assessment of microinflammation in haemodialysis patients. Nephrol Dial Transplant 2004;19: 150–7.
   PubMed Web of Science ®Google Scholar
• Kalousová M, Bartošová K, Zima T, Skibová J, Teplan V, Viklický O. Pregnancy-associated plasma protein A and soluble receptor for advanced glycation end products after kidney transplantation. Kidney Blood Press Res 2007;30:31–7.
   PubMed Web of Science ®Google Scholar
• Fialova L, Kalousova M, Soukupova J, Sulkova S, Merta M, Jelinkova E, Horejsi M, Sramek P, Malbohan I, Mikulikova L, Tesar V, Zima T. Relationship of pregnancy-associated plasma protein A (PAPP-A) to renal function and dialysis modalities. Kidney Blood Press Res 2004;27:88–95.
   PubMed Web of Science ®Google Scholar
• Cosin-Sales J, Christiansen M, Karminski P, Oxvig C, Overgaard MT, Cole D, Holt DW, Kaski JC. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 2004;109:1724–8.
   PubMed Web of Science ®Google Scholar
• Mueller T, Dieplinger B, Poelz W, Haltmayer M. Increased pregnancy-associated plasma protein A as a marker for peripheral atherosclerosis: results from the Linz Peripheral Arterial Disease Study. Clin Chem 2006;52:1096–103.
   Google Scholar
• Neyra NR, Hakim RM, Shyr Y, Ikitzler TA. Serum transferrin and serum prealbumin are early predictors of serum albumin in chronic hemodialysis patients. J Ren Nutr 2000;10:184–90.
   PubMedGoogle Scholar
• Gross S, van Ree RM, Oterdoom LH, de Vries APJ, van Son WJ, de Jong PE, Navis GJ, Zuurman MW, Bierhaus A, Gans ROB, Bakker SJL. Low levels of sRAGE are associated with increased risk for mortality in renal transplant recipients. Transplantation 2007;84:659–63.
   PubMed Web of Science ®Google Scholar
• Bopp C, Hofer S, Weitz J, Bierhaus A, Nawroth PP, Martin E, Buchler MW, Weigand MA. sRAGE is elevated in septic patients and associated with patients outcome. J Surg Res 2008;147:79–83.
   PubMed Web of Science ®Google Scholar
• Nakamura K, Yamagishi S, Adachi H, Matsui T, Kurita-Nakamura Y, Matsui T, Yoshida T, Imaizumi T. Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes. Mol Med 2007;13:185–9.
   PubMed Web of Science ®Google Scholar
• Nienhuis HL, K. de Leeuw K, Bijzet J, Smit A, Schalkwijk CG, Graaff R, Kallenberg CG, Bijl M. Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of AGE. Rheumatology 2008;47:1554–8.
   PubMed Web of Science ®Google Scholar
• Germanová A, Koucký M, Hájek Z, Par ízek A, Zima T, Kalousová M. Soluble receptor for advanced glycation end products in physiological and pathological pregnancy. Clin Biochem 2010;43:442–6.
   Google Scholar
• Hájek Z, Koucký M, Zima T, Kopecký P, Vítková M, Pařízek A, Kalousová M. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study. J Perinat Med 2008;36:339–404.
   Google Scholar
• Chavakis T, Bierhaus A, Al-Fakhri N, Schneider D, Witte S, Linn T, Nagashima M, Morser J, Arnold B, Preissner KT, Nawroth PP. The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 2003;198: 1507–15.
   PubMed Web of Science ®Google Scholar
• Pullerits R, Brisslert M, Jonsson IM, Tarkowski A. sRAGE triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1. Arthritis Rheum 2006;54:3898–907.
   PubMed Web of Science ®Google Scholar
• Yonekura H, Yamamoto Y, Sakurai S, Petrova RG, Abedin MJ, Li H, Yasui K, Takeuchi M, Makita Z, Takasawa S, Okamoto H, Watanabe T, Yamamoto H. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem J 2003;370:1097–109.
   PubMed Web of Science ®Google Scholar
• Basta G, Leonardis D, Mallamaci F, Cutrupi S, Pizzini P, Gaetano L, Tripepi R, Tripepi G, De Caterina R, Zoccali C. Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease. Kidney Int 2010;77:225–31.
   PubMed Web of Science ®Google Scholar
• Babazoni T, Hanai K, Suzuki K, Kiuchi Y, Inoue A, Tanaka M, Hase M, Ishii A, Iwamoto Y. Lower haemoglobin level and subsequent decline in kidney function in type 2 diabetic adults without clinical albuminuria. Diabetologia 2006;49: 1387–93.
   Google Scholar